| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Applied Optoelectronics (AAOI) | Raymond James/ Piper Jaffray | $50.00 | n.a. | |||
| Benefitfocus (BNFT) | Goldman, Sachs/ Deutsche Bank Securities/ Jefferies | $75.00 | n.a. | |||
| BIND Therapeutics (BIND) | Credit Suisse/ Cowen and Company | $80.50 | n.a. | |||
| Chegg (CHGG) | J.P. Morgan/ BofA Merrill Lynch | $150.00 | n.a. | |||
| Fate Therapeutics (FATE) | Cowen and Company/ BMO Capital Markets | $69.00 | n.a. | |||
| Ophthotech (OPHT) | Morgan Stanley/ J.P. Morgan | $85.00 | n.a. | |||
| QTS Realty Trust (QTS) | Goldman, Sachs/ Jefferies | $100.00 | n.a. | |||
| Rocket Fuel (FUEL) | Credit Suisse/ Citigroup | $100.00 | n.a. | |||
| Springleaf Holdings (TBA) | TBA | $50.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Springleaf REIT (TBA) | TBA | $500.00 | n.a. | |||
| Votorantim Cimentos S.A. (VEBM) | Morgan Stanley/ J.P. Morgan/ Itaú BBA/ Credit Suisse/ BTG Pactual | 400.00 | $15.59 | $18.59 | $6,836.00 | 1-Star |
| New Terms | ||||||
| Covisint (COVS) | Credit Suisse/ Pacific Crest Securities | $100.00 | n.a. | |||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Aug. 12, 2013 | Manager(s) | Offered | Raised | Price | 8/16/13 | Change |
| China Commercial Credit (CCCR) | Burnham Securities | 1.37 | $8.91 | $6.50 | $10.27 | 58.00% |
| Envision Healthcare Holdings (EVH) | Goldman, Sachs/ Barclays/ BofA Merrill Lynch/ Citigroup | 42.00 | $966.00 | $23.00 | $25.70 | 11.74% |
| Third Point Reinsurance (TPRE) | J.P. Morgan/ Credit Suisse/ Morgan Stanley/ BofA Merrill Lynch/ Citigroup | 22.22 | $277.78 | $12.50 | $13.30 | 6.40% |
| Independence Realty Trust (IRT) | Ladenburg Thalmann/ Compass Point/ JMP Securities | 4.00 | $34.00 | $8.50 | $8.30 | -2.35% |
| Sophiris Bio (SPHS) | Citigroup/ Leerink Swann | 13.00 | $65.00 | $5.00 | $4.15 | -17.00% |
